Treatment fidelity, or consistent therapist adherence and competence in intervention delivery, is an important component of intervention design and dissemination. Yet, few systems have been developed to assess fidelity in telepsychology and related remotely-delivered intervention venues. We sought to modify and evaluate a fidelity coding approach for a videoconference-delivered group Cognitive Behavioral Stress Management (CBSM) intervention.
View Article and Find Full Text PDFIntroduction: Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) experience cognitive problems with attention, information processing speed, working memory, learning efficiency, and executive function. Commonly, patients report worsening of cognitive symptoms over time after physical and/or cognitive challenges. To determine, monitor, and manage longitudinal decrements in cognitive function after such exposures, it is important to be able to screen for cognitive dysfunction and changes over time in clinic and also remotely at home.
View Article and Find Full Text PDFObjective: Long COVID is a major health concern because many patients develop chronic neuropsychiatric symptoms, but the precise pathogenesis is unknown. Matrix metalloproteinase-9 (MMP-9) can disrupt neuronal connectivity and be elevated in patients with long COVID.
Methods: In this study, MMP-9 was measured in the serum of long COVID patients and healthy controls, as well as in the supernatant fluid of cultured human microglia cell line stimulated by recombinant severe acute respiratory syndrome coronavirus 2 Spike protein, as well as lipopolysaccharide (LPS) and neurotensin (NT) used as positive controls.